Skip to main content
. 2014 Dec 1;7(12):8823–8832.

Table 4.

Clinic-pathological and treatment data of the retrieved manuscript

Author, year Period Country Cases (n) % of paranasal malignacies M:F ratio Median Age(Range) T stage (%) N+ (%) M+ (%) Prevalent treatment Local recurrence Surgical margins Overall Survival 5-years

T 1-2 T 3-4
Marchetta FC, 1969 [5] 1935-1965 USA (Buffalo) 119 85.0% 1:0.61 - 22% 78% 10% - RT only (53.8%) - - -
Pezner RD, 1979 [6] 1960-1976 USA (Washington) 63 - 1:0.43 63.0 (32-94) 7.9% 92.1% 20.6% - - - - -
St-Pierre S, 1983 [7] 1964-1975 USA (Ann Arbor) 66 - 1:0.57 60.0 (25-89) 13.6 86.4% 10.6%* 12.0% RT + Sx (48.5%) - - 27.3%
Kondo M, 1984/1985 [8,9] 1967-1979 Japan (Tokyo) 97 - 1:0.45 57.3 (30-84) 3.1% 96.9% 12.4% 2.1% RT + ChT + S (most) 48.5% - -
Okawa T, 1989 [10] 1969-1985 Japan (Tokyo) 76 - 1:0.55 61 (31-84) 12% 88% 18%* - RT + ChT + S (78%) - - 43.3%
Lavertu P, 1989 [11] 1977-1986 USA (Cleveland) 48 46.6% 1:0.8+ 60.3 (23-80)+ 25.0% 75.0% 14.6%* 4.2%* RT + Sx (41.6%) 52.1% 18.75% 38.2%
Kudo K, 1992 [12] 1974-1988 Japan (Morioko) 30 - 1:0.43 56.9 (30-83) 6.6% 94.4% 26.6% 30% - 36.6% - 55.4%
Stern SJ, 1993 [13] 1971-1986 USA (Texas) 85 - 1:0.44 60.2 (14-91) - - 16.9%* 3.6%* Sx+ RT (40.0) - - -
Paulino AC, 1997 [14] 1971-1995 USA (Chigaco) 42 - 1:0.20 63.5 (42-77) 14.3% 85.7% 9.5%* 11.9% Sx+ RT (73.8) 45.3% - -
Itami J, 1998 [15] 1973-1992 Japan (Tokyo) 37 - 1:0.61 63 (40-85) 18.9% 81.1% 18.9% 10.8% Sx+ RT (86.5) 40.5% - -
Konno A, 1998 I [16] 1971-1982 Japan (Akita) 74 - 1:0.54 58.8 (-) 12.2% 87.8% 10.8% 16.2% RT + ChT + S (100%) 5.4% - 68.9%
Konno A, 1998 II [16] 1982-1987 Japan (Akita) 23 - 1:0.39 57.9 (-) 3.1% 96.9% 9.4% 9.4% RT + ChT + S (100%) 6.3% - 75.0%
Kim GE, 1999 [17] 1984-1993 Korea (Seoul) 116 - 1:0.31 55 (23-85) 6.0% 94.0% 10.3%* 1.8% RT alone (80.2%) 49.1% 39.1% 30.5%
Passali D, 1999 [18] - Italy (Siena) 36 - 1: 0.24 65.5 (41-76) 0% 100% 8,30% 16% RT alone (58.3%) 63% - 17%
Tiwari R, 1999 [19] 1975-1994 Netherlands (Amsterdam) 43 73.0% 1:0.53 (32-90) [16.2%] [83.8%] 4.1%* - S + RT (60.5%) - - -
Jeremic B, 2000 [20] 1987-1993 Yugoslavia (Kragujevac) 44 - 1:0.22 - - 100% - 9.1% RT + Sx (100.0%) 29.5% - 66%
Waldron J, 2000 [21] 1976-1993 Canada (Toronto) 110 61% 1:0.43 64 (38-89) 16% 84% 15% 10.9% RT alone (75.5%) 57.3% 25% 30.0%
Hayashi T, 2001 [22] 1983-1997 Japan (Asahikawa) 74 - 1:0.42 66 (34-86) 12.2% 87.8% 10.8%* 1.4%* RT + ChT + S (83.8%) 13.5% 3.4% 58.5%
Ogawa K, 2001 [23] 1979-1998 Japan (Nishihara-cho) 41 - 1:0.28 55 (37-79) 14.6% 85.4% 12.2%* 7.3% S + RT (100.0%) 41% 65.8% 48%
Yoshimura R, 2002 [24] 1977-1996 Japan (Tokyo) 110 - 1:0.40 57 (26-84) 20.0% 80.0% 15.5% - RT + ChT + S (100%) 26.4% - 63%
Isobe K, 2005 [25] 1983-2002 Japan (Chiba) 124 - 1:0.3 60.8 (30-82) 7.3% 92.7% 16.9%* - RT + ChT + S (100%) - - 56.6
Qureshi SS, 2006 [26] 1994-1999 India (Mumbai) 62 - 1:0.59 55 (15-70) 16.2% 83.8% 8% 1.6% Sx+ RT (65.0) 45% 37.5% 35%
Nishimura G, 2009 [27] 1991-2007 Japan (Yokohama) 41 63.1% 1:0.1 59.5 (34-81) 2.5% 97.5% 10% 2.5% S + ChT + RT (40.0%) 29.4% - 59.2
Ashraf M, 2010 [28] 1979-2005 India (Kolkata) 379 - 1:0.38 47.2 (23-67) 7.4% 92.6% 16.6% 11.4% Sx+ RT (59.4%) 49.3% - 53%
Hinerman, 2011 [29] 1969-2006 USA (Florida) 54 - 1:0.6 62 (36-79) 3.7% 96.3% 33.3% 24% RT alone (54%) - - 30%
Kreppel M, 2012 [30] 1980-2006 Germany (Cologne) 53 - 1:0.3 57.9 (18-78) 5.7% 94.3% 47.1% - RT + ChT + S (100%) 34.0% - 35.0%
Present data 1997-2006 Brazil (Rio de Janeiro) 58 43.5% 1:0.40 58.7 (19-89) 8.6% 91.4% 17.2% 8.6% RxT + ST (37.9%) 20.4% 39.4% 17.7%

%: percentage;

*

at first appointment;

[]: Stage; ChT: chemotherapy; F: female; M: male; n: number; N+: positive cervical nodes; M+: positive distant metastasis; RT: radiotherapy; S: surgery; T: tumor.